NMN (nicotinamide mononucleotide) utilizes an advanced liposomal delivery technology to significantly improve the absorption and bioactivity of NMN. This results in a rapid increase in NAD+ (nicotinamide adenine dinucleotide) in users, not only in plasma but also importantly intracellularly. Natroceutics NMN offers an efficient and effective solution for raising NAD+ concentrations in all users where it counts, within the cell.